Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13077266 | 1.00 | DPP4 (0.45) | DPP4F2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL3469048 | 1.00 | DPP4 (0.45) | DPP4F2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL21554360 | 0.85 | DPP4 (0.41) | DPP4F2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL12199461 | 0.84 | CYP3A4 (0.38) | DPP4F2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL2738406 | 0.83 | KDM4E (0.43) | DPP4F2 | |
| SCHEMBL21165081 | 0.76 | EPHX1 (0.38) | CYP3A4CYP1A2CYP2D6TSHRMAPK1 | |
| SCHEMBL14479727 | 0.76 | SIGMAR1 (0.34) | SIGMAR1 | |
| SCHEMBL20311848 | 0.76 | AOC3 (0.33) | CYP3A4CYP1A2TSHRHSD17B10 | |
| SCHEMBL18726338 | 0.74 | CYP2D6 (0.35) | DPP4CYP3A4CYP1A2CYP2D6TSHR | |
| SCHEMBL5948196 | 0.73 | HRH1 (0.43) | CYP3A4CYP1A2CYP2D6TSHRSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | MPI, ITPA, DCPS | DPP4 3543/4885F2 988/4885CYP3A4 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.